Home/ Stocks/ VTRS

Viatris Inc. Common Stock

VTRS XNAS

$19.91 +0.88 (+4.64%) ▲ 15-min delayed

Open

$18.79

High

$19.94

Low

$18.79

Volume

14.53M

Market Cap

$22.83B

About Viatris Inc. Common Stock

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up one-third of Viatris' total sales. The remaining sales are derived from its portfolio of legacy products, including Lipitor, Norvasc, Lyrica, and Viagra.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 30.0K Website →

Related Market News

No specific coverage for VTRS yet. Check out our latest market news or earnings calendar.

Get VTRS Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Viatris Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.